LongBio Pharma Lists on Hong Kong Stock Exchange: A Leader in Allergic and Autoimmune Disease Innovation in China
June 5, 2026 — 18:40 CST
This Data Is Locked!
This area is available only to Subscribers.
LongBio Pharma, a leading innovative drug developer for allergic and autoimmune diseases in China, recently listed on the Hong Kong Stock Exchange. The company issued... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
